Anti-Inflammatory Therapeutics Market Size is projected to reach USD 141.58 billion by 2030, growing at a CAGR of 3.8%: Straits Research
September 07, 2023 09:00 ET
|
Straits Research
New York, United States, Sept. 07, 2023 (GLOBE NEWSWIRE) -- Anti-inflammatory therapeutic is a drug that eases chronic pain as well as inflammation. These agents block certain substances in the body...
SPR Therapeutics Announces 20,000th Patient Implant of SPRINT® PNS System
August 22, 2023 10:00 ET
|
SPR Therapeutics, Inc.
CLEVELAND, Aug. 22, 2023 (GLOBE NEWSWIRE) -- SPR® Therapeutics, a private medical device company focused on treating pain and improving the quality of life for patients managing acute or chronic...
Canadian Military Veterans Bring Awareness and Education to Chronic Pain Through Annual Hike Event
August 21, 2023 08:20 ET
|
Chronic Pain Centre of Excellence for Canadian Veterans
HAMILTON, Ontario, Aug. 21, 2023 (GLOBE NEWSWIRE) -- Ten military Veterans living with chronic pain from across Canada completed the second annual Military Veterans Alpine Challenge (Alpine...
Curonix Provides Reimbursement Update on Neurostimulator Procedure Codes
July 18, 2023 08:00 ET
|
Curonix LLC
POMPANO BEACH, Fla., July 18, 2023 (GLOBE NEWSWIRE) -- Today, Curonix LLC provided an update on the Medicare Physician Fee Schedule Proposed Rule published by the Centers for Medicare & Medicaid...
Neurostimulation Devices Market revenue to hit USD 34 Billion by 2035, says Research Nester
July 11, 2023 07:00 ET
|
Research Nester
New York, July 11, 2023 (GLOBE NEWSWIRE) -- The global neurostimulation devices market is expected to grow at a CAGR of ~12% from 2023 to 2035. The market is estimated to garner a revenue of ~USD 34...
TAC-STIM™ Non-Invasive Vagal Nerve Stimulation Selected for Inclusion in the Air Force Research Laboratories Real-Time Assessing and Augmenting Cognitive Performance in Extreme Environments Project
June 27, 2023 08:00 ET
|
electroCore, Inc.
ROCKAWAY, N.J., June 27, 2023 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced that its TAC-STIM non-invasive...
New Active Relaxation Product Empowers Pain Sufferers to Overcome Stress, Anxiety, and Sleepless Nights
June 15, 2023 10:00 ET
|
Avaria Health & Beauty Corp
TORONTO, June 15, 2023 (GLOBE NEWSWIRE) -- Canadians experiencing pain can now find solace in KaLaya's new, Vegan Blueberry Active Relaxation Gummies. These gummies are designed to alleviate stress,...
electroCore to Participate in the Healthcare Virtual Conference Presented by Maxim Group LLC
June 14, 2023 08:00 ET
|
electroCore, Inc.
ROCKAWAY, N.J., June 14, 2023 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that Company CEO, Dan Goldberger,...
electroCore Announces Poster to be Presented at the American Headache Society’s 65th Annual Scientific Meeting
June 13, 2023 08:00 ET
|
electroCore, Inc.
ROCKAWAY, N.J., June 13, 2023 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that “SUNCT/ SUNA with...
Neurostimulation Devices Market Revenue is Predicted to Surpass a Valuation of US$ 36.5 billion by 2032, States by Market.us
May 24, 2023 06:57 ET
|
Market.Us
New York, May 24, 2023 (GLOBE NEWSWIRE) -- The Neurostimulation Devices Market stood at US$ 11.1 billion in 2022 and the global market is projected to reach US$ 36.5 billion by 2032. The global...